Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report)’s share price rose 50% on Wednesday . The company traded as high as C$0.11 and last traded at C$0.11. Approximately 1,942,446 shares changed hands during trading, an increase of 1,822% from the average daily volume of 101,063 shares. The stock had previously closed at C$0.07.
Voyageur Pharmaceuticals Stock Performance
The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21. The company has a 50-day moving average price of C$0.07 and a two-hundred day moving average price of C$0.06. The stock has a market capitalization of C$13.95 million, a P/E ratio of -10.00 and a beta of 0.32.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Further Reading
- Five stocks we like better than Voyageur Pharmaceuticals
- Investing in the High PE Growth Stocks
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- What Are Dividend Achievers? An Introduction
- 2 Underrated Quantum Computing Companies Starting to Rally
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
